Shi F - Search Results

1

Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.

Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F, Shi R. Naren D, et al. Among authors: shi r, shi f. Leuk Res. 2016 Mar;42:59-67. doi: 10.1016/j.leukres.2016.01.007. Epub 2016 Jan 16. Leuk Res. 2016. PMID: 26818574

2

[The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph ⁺ALL Cell Line].

Wu JH, Shi FF, Gong YP, Shi R. Wu JH, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Mar;48(2):216-220. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 28612529 Chinese.

3

Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+ acute lymphoblastic leukemia cells.

Yang X, He G, Gong Y, Zheng B, Shi F, Shi R, Yang X. Yang X, et al. Among authors: shi r, shi f. Eur J Haematol. 2014 Feb;92(2):111-20. doi: 10.1111/ejh.12202. Epub 2014 Jan 6. Eur J Haematol. 2014. PMID: 24112092

4

The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.

Shi R, Lin J, Gong Y, Yan T, Shi F, Yang X, Liu X, Naren D. Shi R, et al. Among authors: shi f. Anticancer Drugs. 2015 Oct;26(9):913-22. doi: 10.1097/CAD.0000000000000266. Anticancer Drugs. 2015. PMID: 26186064

5

Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.

Shi F, Len Y, Gong Y, Shi R, Yang X, Naren D, Yan T. Shi F, et al. Among authors: shi r. PLoS One. 2015 Aug 28;10(8):e0136746. doi: 10.1371/journal.pone.0136746. eCollection 2015. PLoS One. 2015. PMID: 26317515 Free PMC article.

6

The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.

Shi F, Yang X, Gong Y, Shi R, Yang X, Naren D, Wu J. Shi F, et al. Among authors: shi r. Anticancer Drugs. 2015 Apr;26(4):410-21. doi: 10.1097/CAD.0000000000000200. Anticancer Drugs. 2015. PMID: 25535978

7

Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells.

Guo Y, Shan Q, Gong Y, Lin J, Shi F, Shi R, Yang X. Guo Y, et al. Among authors: shi r, shi f. Pharmazie. 2014 Mar;69(3):229-33. Pharmazie. 2014. PMID: 24716415

8

[Comparative study on biological characteristics between different generations of rabbit nucleus pulposus cells].

Chen Q, Shi F, Yang X, Liu L, Song Y. Chen Q, et al. Among authors: shi f. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 Jun 15;32(6):660-667. doi: 10.7507/1002-1892.201707017. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018. PMID: 29905041 Free PMC article. Chinese.

9

Lentivirus-shRNA Mediated Prolyl Hydroxylase 2 Knockdown Increases HIF-1α and Inhibits Nucleus Pulposus Cells Degeneration.

Chen Q, Shi F, Yang C, Mao G, Zhou C, Liu L, Yang X, Song Y. Chen Q, et al. Among authors: shi f. Cells Tissues Organs. 2023;212(2):185-193. doi: 10.1159/000520795. Epub 2021 Nov 15. Cells Tissues Organs. 2023. PMID: 34781297

10

[COX-2 inhibitor celecoxib can suppress the proliferation of FLT3-ITD positive acute myeloid leukemia cells with prominent down regulation of MEK/MCL-1 expression in vitro].

Du LX, Jia YQ, Meng WT, Shi FF, Zhong XS, Ma LL, Yuan J, Zeng JS. Du LX, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1157-61. doi: 10.7534/j.issn.1009-2137.2013.04.014. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24156425 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,411 results

Search Page

Filters